Drug application
OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM)
Drugs@FDA ANDA 213201 · AUROBINDO PHARMA LTD
Key facts
| Drug name | OMEPRAZOLE MAGNESIUM |
|---|---|
| Active ingredients | OMEPRAZOLE MAGNESIUM |
| Application type | ANDA |
| Application number | 213201 |
| Company | AUROBINDO PHARMA LTD |
| Dosage forms | CAPSULE, DELAYED RELEASE, ORAL |
| Strength | EQ 20MG BASE |
| Marketing status | Over-the-counter |
| Reference listed drug | No |
| Latest submission status date | Apr 28, 2023 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.